Related Experiment Video

Updated: Jun 20, 2026

Cell-Free Dot Blot as a Practical and Adaptable Immunoassay Platform for the Detection of Antibody Response in Human and Animal Sera
08:21

Cell-Free Dot Blot as a Practical and Adaptable Immunoassay Platform for the Detection of Antibody Response in Human and Animal Sera

Published on: May 23, 2025

Clinical value of a competitive NT-proBNP enzyme immunoassay compared to the Roche NT-proBNP platform

Angelika Hammerer-Lercher, Andrea Griesmacher, Gerhard Pölzl

    Clinical Chemistry and Laboratory Medicine
    |September 16, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Integration of Miniaturized Solid Phase Extraction and LC-MS/MS Detection of 3-Nitrotyrosine in Human Urine for Clinical Applications08:41

    Integration of Miniaturized Solid Phase Extraction and LC-MS/MS Detection of 3-Nitrotyrosine in Human Urine for Clinical Applications

    Published on: July 14, 2017

    Probe-based Real-time PCR Approaches for Quantitative Measurement of microRNAs10:28

    Probe-based Real-time PCR Approaches for Quantitative Measurement of microRNAs

    Published on: April 14, 2015

    Related Concept Videos

    Enzyme-Linked Immunosorbent Assay01:33

    Enzyme-Linked Immunosorbent Assay

    In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
    There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.